Incidence and Mortality of Colorectal Cancer in Asia in 2022 and Projections for 2050
Journal of Gastroenterology and Hepatology · 2025-05 · 40 (5) · 1143-1156
DOI: 10.1111/jgh.16910 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 28.02.2025. Verfasst von Mengxia Fu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Galactophore Department, Galactophore Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 53 Literaturangaben.
Abstract (Originalsprache)
Background
Colorectal cancer is an escalating public health concern in Asia, characterized by unique epidemiological patterns.
Methods
We analyzed colorectal cancer data from 47 Asian countries using GLOBOCAN 2022. Spearman's correlation assessed the relationship between the Human Development Index and cancer rates. Projections for 2050 incidence and mortality were based on demographic forecasts.
Results
In 2022, Asia accounted for 50.2% of global colorectal cancer cases, with 966.4 thousand new cases and 462.3 thousand deaths, including 10% in younger individuals. Age‐standardized rates of incidence and mortality were 15.6/100 000 and 7.1/100 000, respectively. Incidence rates were rising faster in younger and male individuals. A significant correlation was found between the Human Development Index and cancer rates. Japan had the highest incidence rate (45.5/100 000 males; 28.5/100 000 females), and Brunei Darussalam had the highest mortality rate (21/100 000 males; 13.9/100 000 females). China recorded the highest incidence and mortality counts, with 307.7 thousand new cases and 142.6 thousand deaths in males, and 209.4 thousand new cases and 97.4 thousand deaths in females. By 2050, 1.87 million new cases and 1.01 million deaths are expected to occur in Asia, with the largest relative increases occurring in low HDI countries.
Conclusions
These findings highlight the need for targeted policies in low HDI countries, focusing on public awareness, early detection, prevention, and improving healthcare infrastructure. Interventions for younger individuals and males are also essential to address rising incidence rates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Galactophore Department, Galactophore Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
- Department of Gastrointestinal Oncology, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
ORCID-Profile: Mengxia Fu, Jian Wang
Zitieren
APA
Fu, M., Li, Y., & Wang, J. (2025). Incidence and Mortality of Colorectal Cancer in Asia in 2022 and Projections for 2050. Journal of Gastroenterology and Hepatology, 40(5), 1143-1156. https://doi.org/10.1111/jgh.16910
Vancouver
Fu M, Li Y, Wang J. Incidence and Mortality of Colorectal Cancer in Asia in 2022 and Projections for 2050. Journal of Gastroenterology and Hepatology. 2025;40(5):1143-1156. doi:10.1111/jgh.16910
BibTeX
@article{Fu2025,
author = {Fu, Mengxia and Li, Yanping and Wang, Jian},
title = {Incidence and Mortality of Colorectal Cancer in Asia in 2022 and Projections for 2050},
journal = {Journal of Gastroenterology and Hepatology},
year = {2025},
volume = {40},
number = {5},
pages = {1143--1156},
doi = {10.1111/jgh.16910}
}
EUVIMED